'cardiovascular risks flibanserin'

Empagliflozin and metformin combination is used with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. It is also used to lower the risk of cardiovascular death in patients with type 2 diabetes and heart or blood vessel disease.

Empagliflozin 25mg and Linagliptin 5mg tablets (Glyxambi) are used to improve blood sugar control in adults with type 2 diabetes, often used alongside diet and exercise, and may also reduce the risk of death from heart problems in those with type 2 diabetes and cardiovascular disease.

Empagliflozin 10 mg and Linagliptin 5 mg tablets, sold as Glyxambi, are used to improve blood sugar control in adults with type 2 diabetes, often as an adjunct to diet and exercise, and can also help reduce the risk of cardiovascular death in those with existing heart disease

Femlib Flibanserin 100mg Tablets is used for treating women with hypoactive sexual desire disorder (HSDD), or low sex drive or desire for sex. This medication is approved for women who haven't gone through menopause yet. It's a tablet that you take once a day at bedtime. Flibanserin side effects include dizziness, sleepiness, and nausea. Because this medication also has a risk for low blood pressure and fainting, there are some alcohol limitations with treatment.

Orlifit-N-Slim 120 Capsule is a medicine used in the treatment of obesity. It helps the body in blocking the absorption of fats from the small intestines and stomach. This way it can help reduce calorie intake and weight loss over time.